Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) |
Count of active ingredient |
quatre |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) |
Plays role |
Active immunity stimulant role (role) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Influenza A virus subtype H3N2 antigen |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Influenza B virus Yamagata lineage antigen |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Influenza B virus Victoria lineage antigen |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Influenza A virus subtype H1N1 antigen |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
|
Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) |
Is a |
Vaccine product containing only Influenza A virus subtype H1N1 antigen (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) |
Is a |
Influenza virus antigen only vaccine product |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|